Written and maintained by CASRAI Editorial Board
Last updated
ACSM risk stratification refers to the clinical and fitness preparticipation screening frameworks published by the American College of Sports Medicine (ACSM) in ACSM’s Guidelines for Exercise Testing and Prescription to evaluate an individual’s risk of exercise-related cardiovascular events—such as sudden cardiac death or acute myocardial infarction—prior to initiating or progressing an exercise program. In clinical cardiopulmonology and outpatient rehabilitation, ACSM guidelines operate in tandem with the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) risk stratification criteria, which classify patients with established cardiovascular disease into Low, Moderate, and High Risk tiers.
While hospital-based acute care teams rely on inpatient cardiac risk stratification tools (such as HEART, TIMI, GRACE, and RCRI) or PE risk stratification models, exercise physiologists, physical therapists, cardiac rehabilitation directors, and clinical trial investigators use the ACSM preparticipation algorithm and the AACVPR risk stratification chart to determine when medical clearance, graded exercise testing (GXT), or continuous electrocardiographic (ECG) telemetry supervision is required.
What Is a Risk Stratification Model in Fitness?
In exercise science and preventive cardiology, a risk stratification model in fitness is a structured decision algorithm that triages individuals before exercise testing or training based on their habitual physical activity level, clinical history, signs or symptoms of cardiopulmonary or metabolic pathology, and objective physiological measurements (such as left ventricular ejection fraction and metabolic equivalents [METs]).
Historically—through the 9th edition of ACSM’s Guidelines for Exercise Testing and Prescription—the ACSM risk stratification meaning centered on counting atherosclerotic cardiovascular disease (CVD) risk factors (age, family history, cigarette smoking, sedentary lifestyle, obesity, hypertension, dyslipidemia, and prediabetes) to classify asymptomatic individuals into Low, Moderate, or High Risk categories:
- Legacy ACSM Low Risk: Asymptomatic men and women with <2 CVD risk factors.
- Legacy ACSM Moderate Risk: Asymptomatic men and women with ≥2 CVD risk factors.
- Legacy ACSM High Risk: Individuals with one or more major signs or symptoms suggestive of cardiovascular, pulmonary, or metabolic disease, or known cardiovascular, pulmonary, or metabolic disease.
The Updated ACSM Preparticipation Screening Guidelines (2015 Consensus / 2018 10th & 11th Editions)
Because traditional CVD risk-factor counting produced high false-positive referral rates that created unnecessary barriers to physical activity, the ACSM updated its preparticipation screening paradigm (Riebe et al., 2015; ACSM’s Guidelines 10th edition [2018] and 11th edition). Rather than tallying lipid and blood pressure thresholds for asymptomatic exercising adults, the modern ACSM risk stratification tool evaluates three core variables:
- Current Regular Exercise Participation: Defined as performing planned, structured physical activity for at least 30 minutes at moderate intensity on at least 3 days per week for at least the past 3 months.
- Known Cardiovascular, Metabolic, or Renal Disease: Includes cardiac, peripheral vascular, or cerebrovascular disease; Type 1 or Type 2 diabetes mellitus; or chronic kidney disease.
- Major Signs or Symptoms Suggestive of Disease:
- Pain or discomfort in the chest, neck, jaw, arms, or other areas that may result from myocardial ischemia
- Shortness of breath at rest or with mild exertion (dyspnea)
- Dizziness or syncope
- Orthopnea or paroxysmal nocturnal dyspnea
- Ankle edema
- Palpitations or tachycardia
- Intermittent claudication
- Known heart murmur
- Unusual fatigue or shortness of breath with usual activities
ACSM Preparticipation Screening Decision Matrix
| Habitual Exercise Status | Disease & Symptom Status | Medical Clearance Recommendation | Recommended Starting Exercise Intensity |
|---|---|---|---|
| Does NOT Exercise Regularly | No known CV/metabolic/renal disease AND asymptomatic | Medical clearance not necessary | Light-to-moderate intensity; may gradually progress to vigorous intensity |
| Does NOT Exercise Regularly | Known asymptomatic CV, metabolic, or renal disease | Medical clearance recommended prior to starting | Light-to-moderate intensity following medical clearance |
| Does NOT Exercise Regularly | Signs or symptoms suggestive of CV, metabolic, or renal disease | Medical clearance required prior to any exercise | Light-to-moderate intensity once medically cleared |
| Exercises Regularly | No known CV/metabolic/renal disease AND asymptomatic | Medical clearance not necessary | May continue moderate or vigorous intensity exercise |
| Exercises Regularly | Known asymptomatic CV, metabolic, or renal disease | Medical clearance not necessary for moderate intensity; recommended before vigorous intensity (within 12 months) | Continue moderate intensity; medical clearance before vigorous progression |
| Exercises Regularly | Signs or symptoms suggestive of CV, metabolic, or renal disease | Discontinue exercise and seek medical clearance | Resume only after medical evaluation and clearance |
AACVPR Risk Stratification Chart for Cardiac Rehabilitation
For patients with diagnosed cardiovascular disease entering outpatient cardiac rehabilitation (Phase II or Phase III), ACSM explicitly adopts the AACVPR risk stratification criteria (published in the AACVPR Guidelines for Cardiac Rehabilitation and Secondary Prevention Programs). The AACVPR model stratifies patients into Low, Moderate, or High Risk for clinical events during exercise training based on left ventricular function, symptom threshold, ischemic ST-segment changes, arrhythmias, and functional capacity in METs (often monitored alongside the Borg Rating of Perceived Exertion).
| Clinical Parameter | AACVPR Low Risk (ALL Criteria Must Be Met) | AACVPR Moderate Risk (Does Not Meet High or Low Criteria) | AACVPR High Risk (ANY ONE Criterion Present) |
|---|---|---|---|
| Left Ventricular Ejection Fraction (LVEF) | Resting LVEF ≥ 50% | Resting LVEF 40% to 49% | Resting LVEF < 40% |
| Functional Capacity (METs) | ≥ 7.0 METs on graded exercise test (or ≥ 5–7 METs without ischemia) | 5.0 to 6.9 METs (or < 5–6 METs without high-risk features) | < 5.0 METs on graded exercise test |
| Myocardial Ischemia (ECG ST-Segment Depression) | Absence of ischemic ST-segment depression during exercise and recovery | Mild-to-moderate silent ischemia (reversible horizontal/downsloping ST depression 1.0 to 1.9 mm) | Severe silent ischemia (ST-segment depression ≥ 2.0 mm) during exercise or recovery |
| Angina or Exercise Symptoms | Absence of angina, unusual dyspnea, dizziness, or lightheadedness during exercise/recovery | Angina or ischemic symptoms occurring only at moderate-to-high workloads (≥ 5–7 METs) | Angina, dizziness, or dyspnea occurring at low workloads (< 5.0 METs) or during recovery |
| Ventricular Dysrhythmias | Absence of resting or exercise-induced complex ventricular dysrhythmias | Non-complex arrhythmias without hemodynamic compromise | Complex ventricular dysrhythmias (e.g., VT, ventricular fibrillation, multiform PVCs) at rest or with exercise |
| Hemodynamic Response to Exercise | Normal rise in systolic BP and heart rate with increasing workload | Mildly blunted blood pressure response without drop | Flat or decreasing systolic BP (>10 mmHg drop) or severe chronotropic incompetence with increasing workload |
| Clinical Course & History | Uncomplicated MI, CABG, or PCI; absence of CHF; absence of clinical depression | Uncomplicated recovery with moderate functional limitation | History of cardiac arrest/sudden death; MI/surgery complicated by cardiogenic shock or CHF; clinically significant depression |
How ACSM and AACVPR Stratification Integrate with EHR and Clinical Workflows
In cardiopulmonary rehabilitation departments and exercise oncology/cardiology clinical trials, the ACSM preparticipation screen and AACVPR risk stratification chart are embedded into electronic health record (EHR) clinical decision support systems (CDSS):
- Automated AACVPR Tier Assignment: When a patient is referred to Phase II cardiac rehabilitation (CPT 93797 / 93798), the EHR intake flowsheet pulls the most recent echocardiogram LVEF (LOINC
10230-1), cardiopulmonary exercise test peak METs, resting/stress ECG findings, and PHQ-9 depression score. If any High-Risk trigger (such as LVEF < 40% or peak workload < 5.0 METs) is present, the rule engine automatically assigns AACVPR High Risk. - Telemetry and Staff-to-Patient Ratio Governance: The AACVPR tier dictates the frequency of continuous 3-lead or 12-lead ECG telemetry monitoring, blood pressure checks during aerobic conditioning, and readiness to graduate from supervised Phase II telemetry sessions to unmonitored Phase III maintenance or remote home-based cardiac rehabilitation.
Frequently Asked Questions
What is a risk stratification model in fitness?
In fitness and clinical exercise physiology, a risk stratification model is a standardized screening tool—most commonly the ACSM preparticipation health screening algorithm or the AACVPR cardiac rehabilitation risk stratification chart—that evaluates an individual’s current exercise habits, known cardiovascular/metabolic/renal diseases, symptoms, and physiological test results to classify their risk of an exercise-induced cardiac event and determine whether medical clearance or ECG supervision is needed.
What is the difference between ACSM risk stratification and AACVPR risk stratification?
The ACSM preparticipation screening algorithm is designed for the general population and fitness settings to determine whether an individual needs medical clearance before starting light, moderate, or vigorous exercise based on regular physical activity habits, known disease, and symptoms. The AACVPR risk stratification chart is a clinical tool (adopted by ACSM for patients with known cardiovascular disease) that classifies cardiac rehabilitation patients into Low, Moderate, or High Risk tiers using LVEF, exercise capacity in METs, ST-segment depression, arrhythmias, and hemodynamic responses.
